{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:30:38Z","timestamp":1762075838229},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1975,1,1]],"date-time":"1975-01-01T00:00:00Z","timestamp":157766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacologia"],"published-print":{"date-parts":[[1975]]},"DOI":"10.1007\/bf00437617","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T20:38:22Z","timestamp":1100205502000},"page":"69-74","source":"Crossref","is-referenced-by-count":130,"title":["Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine"],"prefix":"10.1007","volume":"43","author":[{"given":"B.","family":"Costall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.2042-7158.1972.tb08912.x","volume":"24","author":"N.-E. And\u00e9n","year":"1972","unstructured":"And\u00e9n, N.-E.: Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs. J. Pharm. Pharmacol. 24, 905?906 (1972)","journal-title":"J. Pharm. Pharmacol."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0028-1094313","volume":"4","author":"J. Angst","year":"1971","unstructured":"Angst, J., Bente, D., Berner, P., Heimann, H., Helmchen, H., Hippius, H.: Das klinische Wirkungsbild von Clozapin. Pharmacopsychiat. 4, 201?214 (1971)","journal-title":"Pharmacopsychiat."},{"key":"CR3","first-page":"199","volume":"72","author":"F. Baro","year":"1972","unstructured":"Baro, F., Van Lommel, R., Dom, R., De Mesmaecker, L.: Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach. Acta psychiat. belg. 72, 199?214 (1972)","journal-title":"Acta psychiat. belg."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1476-5381.1972.tb06898.x","volume":"46","author":"G. Bartholini","year":"1972","unstructured":"Bartholini, G., Haefely, W., Jalfre, M., Keller, H. H., Pletscher, A.: Effects of clozapine on cerebral catecholaminergic neurone systems. Brit. J. Pharmacol. 46, 736?740 (1972)","journal-title":"Brit. J. Pharmacol."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000468065","volume":"4","author":"D. P. Bobon","year":"1970","unstructured":"Bobon, D. P., Plomteux, G., Heusghem, C., Bobon, J.: Clinical toxicology and efficacy of pimozide. Int. Pharmacopsychiat. 4, 194?203 (1970)","journal-title":"Int. Pharmacopsychiat."},{"key":"CR6","first-page":"1301","volume":"19","author":"P. Borenstein","year":"1969","unstructured":"Borenstein, P., Champion, C., Cujo, Ph., Gekiers, P., Olivenstein, C., Kramarz, P.: An original psychotropic drug: sulpiride. Sem. H\u00d4p. Paris 19, 1301?1314 (1969)","journal-title":"Sem. H\u00d4p. Paris"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0014-2999(74)90144-7","volume":"27","author":"H. R. Burki","year":"1974","unstructured":"Burki, H. R., Ruch, W., Asper, H., Baggiolini, Stille, G.: Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Europ. J. Pharmacol. 27, 180?190 (1974)","journal-title":"Europ. J. Pharmacol."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/08039487109094678","volume":"25","author":"P. Caille","year":"1971","unstructured":"Caille, P.: Preliminary clinical experience with sulpiride. Nord. psykiat. T. 25, 340?346 (1971)","journal-title":"Nord. psykiat. T."},{"key":"CR9","first-page":"674","volume":"23","author":"B. Costall","year":"1973","unstructured":"Costall, B., Naylor, R. J.: Neuroleptic and non-neuroleptic catalepsy. Arzneimittel-Forsch. 23, 674?683 (1973a)","journal-title":"Arzneimittel-Forsch."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00428687","volume":"32","author":"B. Costall","year":"1973","unstructured":"Costall, B., Naylor, R. J.: Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect? Psychopharmacologia (Berl.) 32, 161?170 (1973b)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0014-2999(74)90019-3","volume":"29","author":"B. Costall","year":"1974","unstructured":"Costall, B., Naylor, R. J.: Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raph\u00e9 nuclei. Europ. J. Pharmacol. 29, 206?222 (1974a)","journal-title":"Europ. J. Pharmacol."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0014-2999(74)90201-5","volume":"27","author":"B. Costall","year":"1974","unstructured":"Costall, B., Naylor, R. J.: Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Europ. J. Pharmacol. 27, 46?58 (1974b)","journal-title":"Europ. J. Pharmacol."},{"key":"CR13","doi-asserted-by":"crossref","unstructured":"Costall, B., Kelly, D. M., Naylor, R. J.: Nomifensine: A potent dopaminergic agonist of antiparkinson potential. Psychopharmacologia (Berl.) (in press 1975)","DOI":"10.1007\/BF00421073"},{"key":"CR14","first-page":"485","volume-title":"The present status of psychotropic drugs","author":"D. Maio De","year":"1969","unstructured":"De Maio, D.: Preliminary clinical evaluation of a new neuroleptic agent: HF 1854 in: The present status of psychotropic drugs, A. Cerletti and F. J. Bov\u00e9, eds., pp. 485?488. Amsterdam: Excerpta Medica Foundation 1969"},{"key":"CR15","first-page":"511","volume":"33","author":"R. L. Dorris","year":"1974","unstructured":"Dorris, R. L., Shore, P. A.: Actions of clozapine on the dopamine neuron. Fed. Proc. 33, 511 (1974)","journal-title":"Fed. Proc."},{"key":"CR16","first-page":"453","volume-title":"Extrapyramidal system and neuroleptics","author":"D. Goldman","year":"1961","unstructured":"Goldman, D.: Parkinsonism and related phenomena from administration of drugs: their production and control under clinical conditions and possible relation to therapeutic effect. In: Extrapyramidal system and neuroleptics. J.-M. Bordeleau, ed., pp. 453?464. Editions psychiatriques, Montreal 1961"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000468119","volume":"9","author":"H. J. Haase","year":"1974","unstructured":"Haase, H. J., Floru, L., Ulrich, F.: Clinical neuroleptic investigation of N-[(1-ethyl-pyrrolidine-2-yl)-methyl]-2-methoxy-5-sulfamoyl benzamide the neuroleptic sulpiride (Dogmatil) using acute schizophrenics. Int. Pharmacopsychiat. 9, 77?94 (1974)","journal-title":"Int. Pharmacopsychiat."},{"key":"CR18","first-page":"183","volume":"32","author":"O. Hornykiewicz","year":"1973","unstructured":"Hornykiewicz, O.: Parkinsons disease: from brain homogenate to treatment. Fed. Proc. 32, 183?190 (1973)","journal-title":"Fed. Proc."},{"key":"CR19","first-page":"841","volume":"17","author":"P. A. J. Janssen","year":"1967","unstructured":"Janssen, P. A. J., Niemegeers, J. E., Schellekens, K. H. L., Lenaerts, F. M.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data. Arzneimittel-Forsch. 17, 841?854 (1967)","journal-title":"Arzneimittel-Forsch."},{"key":"CR20","first-page":"663","volume":"16","author":"Cl. Laville","year":"1968","unstructured":"Laville, Cl., Margarit, J.: Influence of sulpiride on motor activity and vigilance in the mouse. Path. et Biol. 16, 663?665 (1968)","journal-title":"Path. et Biol."},{"key":"CR21","first-page":"47","volume-title":"Modern problems of pharmacopsychiatry, vol. 5","author":"D. M. Loew","year":"1970","unstructured":"Loew, D. M.: The prediction of sedative potency of neuroleptics. In: Modern problems of pharmacopsychiatry, vol. 5, D. P. Bobon, P. A. J. Janssen, and J. Bobon, eds., pp. 47?50. Basel: Karger 1970"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/248596a0","volume":"248","author":"R. J. Miller","year":"1974","unstructured":"Miller, R. J., Hiley, C. R.: Anti-muscarinic properties of neuroleptics and drug induced Parkinsonism. Nature (Lond.) 248, 596?597 (1974)","journal-title":"Nature (Lond.)"},{"key":"CR23","first-page":"759","volume":"10","author":"R. J. Miller","year":"1974","unstructured":"Miller, R. J., Horn, A. S., Iversen, L. L.: The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3?,5?-monophosphate productions in rat neostriatum and limbic forebrain. Molec. Pharmacol. 10, 759?766 (1974)","journal-title":"Molec. Pharmacol."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.2042-7158.1974.tb09222.x","volume":"26","author":"P. Muller","year":"1974","unstructured":"Muller, P., Seeman, P.: Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system. J. Pharm. Pharmacol. 26, 981?984 (1974)","journal-title":"J. Pharm. Pharmacol."},{"key":"CR25","first-page":"981","volume":"24","author":"A. C. Sayers","year":"1974","unstructured":"Sayers, A. C., Kleinlogel, H.: Neuropharmakologische Befunde unter chronischer Verabreichung von Haloperidol, Loxapine und Clozapin. Arzneimittel-Forsch. 24, 981?982 (1974)","journal-title":"Arzneimittel-Forsch."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archpsyc.1974.01760130040006","volume":"31","author":"S. Snyder","year":"1974","unstructured":"Snyder, S., Greenberg, D., Yamamura, H. I.: Antischizophrenic drugs and brain cholinergic receptors. Arch. gen. Psychiat. 31, 58?61 (1974)","journal-title":"Arch. gen. Psychiat."},{"key":"CR27","first-page":"603","volume":"26","author":"G. Stille","year":"1971","unstructured":"Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e) (1,4) diazepine (clozapine). Farmaco, Ed. Sci. 26, 603?625 (1971)","journal-title":"Farmaco, Ed. Sci."},{"key":"CR28","first-page":"675","volume-title":"Phenothiazines and structurally related drugs","author":"O. Vinar","year":"1974","unstructured":"Vinar, O., Kr?iak, M.: Prediction of Neuroleptic effects from animal data. In: Phenothiazines and structurally related drugs, I. S. Forrest, C. J. Carr, and E. Usdin, eds., pp. 675?683. New York: Raven Press 1974"}],"container-title":["Psychopharmacologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00437617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00437617\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00437617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:12:07Z","timestamp":1554837127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00437617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1975]]}},"alternative-id":["BF00437617"],"URL":"https:\/\/doi.org\/10.1007\/bf00437617","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1975]]}}}